Induction of inflammatory bowel disease flares by golimumab: Report of three patients with enteropathic spondylarthritis or ankylosing spondylitis and comorbid colitis

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3640-3641

  Fiehn, Christoph ^a   Vay, Sonja ^a  

^a ACURA Centre for Rheumatic Diseases   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; C REACTIVE PROTEIN; GOLIMUMAB; PREDNISONE;

ABDOMINAL PAIN; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTHRITIS; CASE REPORT; COLITIS; COLONOSCOPY; COMORBIDITY; DIARRHEA; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERITIS; ENTEROPATHIC SPONDYLARTHRITIS; FEMALE; HUMAN; MALE; NOTE; PRIORITY JOURNAL; SPONDYLARTHRITIS; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING;

EID: 80155152490     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30546     Document Type: Note

References (6)

1. Campas-Moya C,. Golimumab: a novel anti-TNF-α human monoclonal antibody for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Drugs Today (Barc) 2010; 46: 13-22.
2. Sandborn WJ, Hanauer SB, Katz S, Safdi M, Wolf DG, Baerg RD, et al. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2001; 121: 1088-94. (Pubitemid 33022088)
3. Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M, et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis 2006; 65: 1631-4. (Pubitemid 44799677)
4. Fouache D, Goeb V, Massy-Guillemant N, Avenel G, Bacquet-Deschryver H, Kozyreff-Meurice M, et al. Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study. Rheumatology (Oxford) 2009; 48: 761-4.
5. Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, et al. Psoriasis induced by tumor necrosis factor-α antagonist therapy: a case series. J Rheumatol 2007; 34: 380-5.
6. Collamer AN, Guerrero KT, Henning JS, Battafarano DF,. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 2008; 59: 996-1001. (Pubitemid 351990997)